Veerhealth Care Limited has announced remarkable unaudited financial results for the quarter and nine months ended December 31, 2025, demonstrating exceptional year-over-year growth across key financial metrics. The Board of Directors approved these results at their meeting held on February 14, 2026, pursuant to Regulation 30 and 33 of the SEBI Listing Regulations.

Outstanding Financial Performance

The company delivered impressive growth metrics for Q3FY26, showcasing strong operational performance:

Detailed Financial Breakdown

The quarterly performance shows strong fundamentals with revenue from operations at ₹725.79 lakhs and total expenses managed at ₹647.02 lakhs:

Strategic Business Developments

Veerhealth Care has achieved several significant milestones positioning it for international expansion. The company received USFDA clearance, enabling exports of Drug (OTC) products to the USA and unlocking access to other international markets. This positions the company among very few small-cap companies globally with USFDA plant clearance.

Key strategic initiatives include discussions with a major Russian group for oral care exports and expected entry into the Russian market soon. The company has also completed onboarding of Ayuver products on Myntra, expanding its e-commerce presence across Amazon and Flipkart platforms.

Manufacturing and Operational Excellence

The company has commenced production at its new facility with in-house plastic molding for packaging and backward integration. Additionally, Veerhealth Care received regulatory approval from Food and Drug Authority, Gujarat for manufacturing personal care products for a leading marketplace company.

Management Outlook and Future Guidance

Managing Director Bhavin Shah expressed confidence in the company's trajectory, stating expectations to maintain high growth rates delivered in Q3FY26. The company has provided ambitious forward guidance with expected total revenues of ₹45-50 crores in FY 2026-27 with PAT margins of 7-10%.

Looking ahead, Veerhealth Care expects to reach revenue of ₹100 crores with PAT of 10% within the next 24 months, supported by expanding international operations and strengthening domestic presence.

Veerhealth Care Ltd has announced the appointment of Ms. Ashita Chittora as the company's new Company Secretary and Compliance Officer, following a board meeting held on February 02, 2026. The appointment takes effect immediately from the same date and was made in compliance with regulatory requirements under the Companies Act, 2013 and SEBI regulations.

Board Meeting Details

The board meeting that approved this appointment commenced at 02.00 P.M. and concluded at 02.30 P.M. on February 02, 2026. The decision was made in accordance with the provisions of Section 203 of the Companies Act, 2013, and Rule made thereunder, as well as Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointee Profile and Qualifications

Ms. Ashita Chittora brings substantial expertise to her new role as Company Secretary and Compliance Officer. She is an Associate Member of the Institute of Company Secretaries of India with membership number A50327, possessing requisite qualifications and skills in secretarial compliances.

Ms. Chittora has undertaken various assignments and possesses good experience in Corporate Law and Listing Regulations, making her well-suited for the compliance responsibilities at Veerhealth Care Ltd.

Regulatory Compliance

The appointment has been made in full compliance with regulatory requirements under Regulation 6(1) & 30(4) read with Para A of Part A of Schedule II of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. The company has provided all details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Information

Veerhealth Care Ltd operates from its registered office at 629-A Gazdar House, 1st Floor, Near Kalbadevi Post Office, J.S.S. Marg, Mumbai - 400 002. The company also has manufacturing works located at Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. 8, Vapi - 396191, Gujarat. The announcement was signed by Managing Director Bhavin Satish Shah (DIN: 03129574), who requested BSE Limited to update their records accordingly.